HANS PETER GULER Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for HANS PETER GULER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of HANS PETER GULER. HANS PETER GULER is VP Clinical Programs in REGENERON PHARMACEUTICALS INC ($REGN) and VP, Clinical Sciences in REGENERON PHARMACEUTICALS INC ($REGN).
Latest Insider Trading Transactions of HANS PETER GULER
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.41 | 1,626 | 12,049 | 0 | |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.44 | 500 | 3,719 | 0 | |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.44 | 8,000 | 59,504 | 500 | |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.44 | 3,500 | 26,033 | 8,500 | |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.44 | 1,500 | 11,157 | 12,000 | |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.44 | 1,500 | 11,157 | 13,500 | |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.41 | 3,374 | 25,001 | 0 | |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.41 | 3,500 | 25,935 | 3,374 | |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.41 | 5,000 | 37,050 | 6,874 | |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.41 | 2,500 | 18,525 | 11,874 | |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 7.91 | 1,626 | 12,862 | 10,530 | 12.2 K to 10.5 K (-13.38 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.41 | 1,626 | 12,049 | 12,156 | 10.5 K to 12.2 K (+15.44 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 7.91 | 3,374 | 26,688 | 10,530 | 13.9 K to 10.5 K (-24.27 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.41 | 3,374 | 25,001 | 13,904 | 10.5 K to 13.9 K (+32.04 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 7.93 | 3,500 | 27,752 | 10,530 | 14 K to 10.5 K (-24.95 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.41 | 3,500 | 25,935 | 14,030 | 10.5 K to 14 K (+33.24 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 7.93 | 5,000 | 39,650 | 10,530 | 15.5 K to 10.5 K (-32.20 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.41 | 5,000 | 37,050 | 15,530 | 10.5 K to 15.5 K (+47.48 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 7.94 | 2,500 | 19,855 | 10,530 | 13 K to 10.5 K (-19.19 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.41 | 2,500 | 18,525 | 13,030 | 10.5 K to 13 K (+23.74 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 7.94 | 500 | 3,971 | 10,530 | 11 K to 10.5 K (-4.53 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.44 | 500 | 3,719 | 11,030 | 10.5 K to 11 K (+4.75 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 7.95 | 8,000 | 63,600 | 10,530 | 18.5 K to 10.5 K (-43.17 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.44 | 8,000 | 59,504 | 18,530 | 10.5 K to 18.5 K (+75.97 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 7.96 | 3,500 | 27,846 | 10,530 | 14 K to 10.5 K (-24.95 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.44 | 3,500 | 26,033 | 14,030 | 10.5 K to 14 K (+33.24 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 7.96 | 1,500 | 11,943 | 10,530 | 12 K to 10.5 K (-12.47 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.44 | 1,500 | 11,157 | 12,030 | 10.5 K to 12 K (+14.25 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 8.10 | 1,500 | 12,146 | 10,530 | 12 K to 10.5 K (-12.47 %) |
| Oct 12 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.44 | 1,500 | 11,157 | 12,030 | 10.5 K to 12 K (+14.25 %) |
| May 06 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Option Exercise | M | 7.44 | 20,000 | 148,760 | 15,000 | |
| May 06 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 13.50 | 2,000 | 27,000 | 10,530 | 12.5 K to 10.5 K (-15.96 %) |
| May 06 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Sell | S | 13.50 | 20,000 | 270,000 | 12,530 | 32.5 K to 12.5 K (-61.48 %) |
| May 06 2004 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP Clinical Program ... | Buy | M | 7.44 | 20,000 | 148,760 | 32,530 | 12.5 K to 32.5 K (+159.62 %) |
| Dec 17 2003 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP, Clinical Scienc ... | Option Exercise | A | 13.00 | 15,000 | 195,000 | 15,000 | |
| Dec 17 2003 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP, Clinical Scienc ... | Option Exercise | A | 13.00 | 5,000 | 65,000 | 5,000 | |
| Dec 17 2003 | REGN | REGENERON PHARMACE ... | GULER HANS PETER | VP, Clinical Scienc ... | Grant | A | 0.00 | 4,077 | 0 | 12,124 | 8 K to 12.1 K (+50.66 %) |
Page: 1